97484-73-6

Usage

Uses

Used in Pharmaceutical Industry:
1-benzyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione is used as a potential antiviral agent for its ability to inhibit viral replication and reduce the severity of viral infections. Its specific antiviral activity and mechanism of action are still under investigation.
1-benzyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione is also used as a potential antitumor agent due to its ability to interfere with tumor cell growth and proliferation. It may act by targeting specific molecular pathways or mechanisms within cancer cells, leading to the suppression of tumor development and progression. Further research is required to fully elucidate its antitumor properties and potential therapeutic applications in oncology.
While the provided materials do not specify different applications in various industries, the primary focus of 1-benzyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione is within the pharmaceutical industry for its potential medicinal uses. Additional applications may be discovered as more research is conducted on 1-benzyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione.

InChI:InChI=1/C14H10N2O3/c17-13-11-7-4-8-15-12(11)16(14(18)19-13)9-10-5-2-1-3-6-10/h1-8H,9H2

Upstream product

• 33522-80-4 2-(benzylamino)nicotinic acid 
• 503-38-8 trichloromethyl chloroformate 
• 100-39-0 benzyl bromide 
• 5860-70-8 2-Aminocarbonylnicotinic acid 
• 21038-63-1 3-azaisatoic anhydride 
• 100-44-7 benzyl chloride 

Downstream Products

• 97484-86-1 2,3-dihydro-10-phenylmethylimidazo<1,2-a>pyrido<2,3-d>pyrimidin-5(10H)-one 
• 686263-53-6 1-benzyl-3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one 
• 179064-00-7 1-benzyl-4-hydroxy-2-oxo-1,2-dihydro[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 847776-02-7 1-benzyl-4-hydroxy-3-(methylsulfonyl)[1,8]naphthyridin-2(1H)-one 
• 847776-10-7 (E) 1-benzyl-4-hydroxy-3-nitro-pyrido[2,3-b]pyridine-2(1H)-one 
• 686266-01-3 ethyl 1-benzyl-4-hydroxy-5-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate 
• 686268-38-2 1-Benzyl-4-hydroxy-3-(5-methoxy-1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-1,8-naphthyridin-2(1H)-one 
• 686262-92-0 1-butyl-3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one 
• 686268-65-5 1-benzyl-4-hydroxy-3-(8-methyl-1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-1,8-naphthyridin-2(1H)-one 
• 686268-60-0 N-[3-(1-benzyl-4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-3-yl)-1,1-dioxido-4H-1,2,4-benzothiadiazin-6-yl]acetamide 
• 686265-76-9 1-benzyl-3-(5-bromo-1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one 
• 686268-57-5 1-benzyl-4-hydroxy-3-(6-methoxy-1, 1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-1,8-naphthyridin-2(1H)-one 
• 111396-26-0 1-(2'-benzylamino-3'-pyridinyl) cyclohexanol 
• 111396-18-0 1-(2'-benzylamino-3'-pyridinyl) cyclopentanol 

Relevant academic research and scientific papers

SUBSTITUTED NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES

Inhibitors of MIF having a naphthyridine backbone are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: (Ia), (Ib), (Ic), (Id) including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein n, R, R1, R2, X, Y and Z are as defined herein. Compositions containing an inhibitor of MIF in combination with a pharmaceutically acceptable carrier are also provided, as well as methods for use of the same.

Anti-infective agents

Compounds having the formula are hepatitis C(HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C(HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.

Anti-infective agents

Compounds having the formula are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.

Anti-infective agents

The present invention provides an HCV polymerase inhibiting compound having the formula (I) and a composition comprising a therapeutically effective amount of said compound. The present invention also provides a method for inhibiting hepatitis C virus (HC

REACTIONS OF αω-BIS(BROMOMAGNESIO)ALKANES WITH HETEROCYCLIC ANHYDRIDES. A NOVEL SYNTHESIS OF FIVE AND SIX-MEMBERED 1-(o-AMINOPHENYL)CYCLOALKANOLS AND 1-(2'-AMINO-3'-PYRIDINYL)CYCLOALKANOLS

Isatoic anhydrides and azaisatoic anhydrides are converted by reaction with 1,4-bis(bromomagnesio)butane and 1,5-bis(bromomagnesio)pentane into the corresponding 1-(o-aminophenyl)cycloalkanols and 1-(2'-amino-3'pyridinyl)cycloalcanols.

The Chemistry of 3-Azaisatoic Anhydrides. Synthesis and Reactions of Polyaza Heterocycles

The preparation of a variety of N-substituted 3-azaisotoic anhydrides 3 and 8 is described.These anhydrides reacted with thiopseudoureas to give interesting bicyclic, tricyclic, and tetracyclic heterocycles many of which are new ring systems.One such hete